Genovese Burford & Brothers Wealth & Retirement Plan Management’s Novartis NVS Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-90	Closed	-$6K	–	268
2018 Q2	$6K	Hold	90	–	–	﹤0.01%	347
2018 Q1	$7K	Hold	90	–	–	﹤0.01%	344
2017 Q4	$8K	Buy	90 +23	+34%	+$1.74K	0.02%	192
2017 Q3	$5K	Hold	67	–	–	﹤0.01%	331
2017 Q2	$5K	Hold	67	–	–	﹤0.01%	314
2017 Q1	$5K	Sell	67 -36	-35%	-$2.4K	﹤0.01%	347
2016 Q4	$7K	Hold	103	–	–	﹤0.01%	356
2016 Q3	$7K	Sell	103 -111	-52%	-$8.09K	﹤0.01%	326
2016 Q2	$15K	Sell	214 -211	-50%	-$14.6K	0.01%	245
2016 Q1	$27K	Buy	425 +278	+189%	+$18.9K	0.01%	182
2015 Q4	$11K	Buy	+147	New	+$11.7K	0.01%	245

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's NVS Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Novartis (NVS) in Q3 2018, closing a stake of 90 shares — an estimated $6K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in NVS in Q4 2015 and held it in 11 quarters. The position peaked at $27K in Q1 2016. 1,029 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 90 Novartis shares in Q3 2018, an estimated $6K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Novartis in Q4 2015 and held it in 11 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Novartis position peaked at $27K in Q1 2016.
1,029 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.